The progress of mother-to-child transmission of Human Immunodeficiency Virus (HIV) after Dolutegravir (DTG) optimization program: evidence from a multicenter cohort study in Ethiopia

The progress of mother-to-child transmission of Human Immunodeficiency Virus (HIV) after Dolutegravir (DTG) optimization program: evidence from a multicenter cohort study in Ethiopia

Abstract Background Ethiopia aims to eliminate mother-to-child transmission (MTCT) of HIV by 2030. In 2020, Dolutegravir-based antiretroviral treatment (ART) regimen optimization was done for the Prevention of Mother-to-Child Transmission (PMTCT). However, data tracking progress, particularly post-r...

Full description

Bibliographic Details
Main Authors: Abel Gedefaw, Birkneh Tilahun Tadesse, Sintayehu Tadesse, Biruk Kebede, Siraj Hussen, Dejene Hailu, Yifru Berhan, Eyasu Makonnen, Stefano Vella, Eleni Aklillu
Format: Article
Language:English
Published: BMC 2024-12-01
Series:BMC Public Health
Subjects:
PMTCT
Pregnancy
Dolutegravir
Ethiopia
Online Access:https://doi.org/10.1186/s12889-024-20761-w

Internet

https://doi.org/10.1186/s12889-024-20761-w

Similar Items